Search

Displaying results 4721 - 4730 of 10000 in total
  1. Drug

    Sipatrigine

    go.drugbank.com/drugs/DB21032
    Experimental

    The usage of the INN stem '-trigine' in the name indicates that Sipatrigine is a sodium channel blocker, signal transduction modulator. Sipatrigine has a monoisotopic molecular weight of 371.05 Da.

  2. Drug

    Nemazoline

    go.drugbank.com/drugs/DB21115
    Experimental

    Nemazoline has a monoisotopic molecular weight of 243.03 Da. … The usage of the INN stem '-azoline' in the name indicates that Nemazoline is a antihistaminic or local vasoconstrictor, antazoline derivative.

  3. Drug

    Ebrotidine

    go.drugbank.com/drugs/DB21220
    Experimental

    The usage of the INN stem '-tidine' in the name indicates that Ebrotidine is a histamine- H2​-receptor antagonist, cimetidine derivative. Ebrotidine has a monoisotopic molecular weight of 475.98 Da.

  4. Drug

    Aloracetam

    go.drugbank.com/drugs/DB21233
    Experimental

    The usage of the INN stem '-racetam' in the name indicates that Aloracetam is a piracetam type amide type nootrope agent. Aloracetam has a monoisotopic molecular weight of 208.12 Da.

  5. Drug

    Oxmetidine

    go.drugbank.com/drugs/DB21430
    Experimental

    The usage of the INN stem '-tidine' in the name indicates that Oxmetidine is a histamine- H2​-receptor antagonist, cimetidine derivative. Oxmetidine has a monoisotopic molecular weight of 399.14 Da.

  6. Drug

    Tisolagiline

    go.drugbank.com/drugs/DB21655
    Experimental

    The usage of the INN stem '-giline' in the name indicates that Tisolagiline is a monoamine oxydase (MAO)-inhibitor type B. Tisolagiline has a monoisotopic molecular weight of 322.13 Da.

  7. Drug

    Mosperafenib

    go.drugbank.com/drugs/DB21673
    Experimental

    The usage of the INN stem '-rafenib' in the name indicates that Mosperafenib is a Raf (rapidly accelerated fibrosarcoma) kinase inhibitor. Mosperafenib has a monoisotopic molecular weight of 461.1 Da.

  8. Drug

    ADH-1

    go.drugbank.com/drugs/DB05485
    Investigational

    At the end of 2006, the Company also completed patient enrollment in our single-agent Phase Ib/II and Phase II trials of ADH-1. … Poorly differentiated, highly invasive carcinomas are characterized by over-expression of N-cadherin (as opposed to E-cadherin).

    Synonyms: l-cysteinamide, n-acetyl-l-cysteinyl-l-histidyl-l-alanyl-l-valyl-, cyclic (1-5)-disulfide
  9. Drug

    3,3'-diindolylmethane

    go.drugbank.com/drugs/DB11875
    Investigational

    Diindolylmethane has been used in trials studying the prevention and treatment of SLE, Prostate Cancer, Cervical Dysplasia, Stage I Prostate Cancer, and Stage II Prostate Cancer, among others.

    Categories: Compounds used in a research, industrial, or household setting
  10. Drug

    Inlexisertib

    go.drugbank.com/drugs/DB21713
    Investigational

    Inlexisertib has a monoisotopic molecular weight of 535.29 Da. … Inlexisertib is under investigation in clinical trial NCT05957367 (A Study of Inlexisertib (DCC-3116) in Combination With Anticancer Therapies in Participants With Advanced Malignancies).